120 related articles for article (PubMed ID: 19520192)
1. Comparative proteomic analysis of colon cancer cells in response to oxaliplatin treatment.
Yao Y; Jia XY; Tian HY; Jiang YX; Xu GJ; Qian QJ; Zhao FK
Biochim Biophys Acta; 2009 Oct; 1794(10):1433-40. PubMed ID: 19520192
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of p110β expression increases chemosensitivity of colon cancer cell lines to oxaliplatin.
Liu W; Wang G; Cao X; Luo X; Li Z; Deng Y; Li X; Wang S; Liu M; Hu J; Wang J
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):280-286. PubMed ID: 22528234
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomic analysis of colon cancer cell HCT-15 in response to all-trans retinoic acid treatment.
Zhao J; Wen G; Ding M; Pan JY; Yu ML; Zhao F; Weng XL; Du JL
Protein Pept Lett; 2012 Dec; 19(12):1272-80. PubMed ID: 22670670
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines.
Lee SY; Kim GT; Roh SH; Song JS; Kim HJ; Hong SS; Kwon SW; Park JH
Biosci Biotechnol Biochem; 2009 Apr; 73(4):811-6. PubMed ID: 19352032
[TBL] [Abstract][Full Text] [Related]
5. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
[TBL] [Abstract][Full Text] [Related]
6. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
7. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.
Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF
Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
10. Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.
Lin J; Hsiao PW; Chiu TH; Chao JI
Biochem Pharmacol; 2005 Sep; 70(5):658-67. PubMed ID: 16004971
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic analysis of cell cycle-dependent apoptosis induced by transforming growth factor-beta.
Tian HY; Zhang KH; Gao X; Lei WW; Zhang L; Yu ML; Song JG; Zhao FK
Biochim Biophys Acta; 2009 Oct; 1794(10):1387-97. PubMed ID: 19450710
[TBL] [Abstract][Full Text] [Related]
12. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
Hua H; Chen W; Shen L; Sheng Q; Teng L
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
[TBL] [Abstract][Full Text] [Related]
13. Profile of protein expression of the colon cancer cell line SW480 with survivin/shRNA.
Wang X; Fu Z; Zhao Y; Wu X; Shen W
Eur J Cancer Prev; 2011 May; 20(3):190-8. PubMed ID: 21200325
[TBL] [Abstract][Full Text] [Related]
14. Thermotherapy enhances oxaliplatin-induced cytotoxicity in human colon carcinoma cells.
Zhang XL; Hu AB; Cui SZ; Wei HB
World J Gastroenterol; 2012 Feb; 18(7):646-53. PubMed ID: 22363135
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS.
Fillet M; Cren-Olivé C; Renert AF; Piette J; Vandermoere F; Rolando Ch; Merville MP
J Proteome Res; 2005; 4(3):870-80. PubMed ID: 15952734
[TBL] [Abstract][Full Text] [Related]
16. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer.
Wu M; Li H; Liu R; Gao X; Zhang M; Liu P; Fu Z; Yang J; Zhang-Negrerie D; Gao Q
Eur J Med Chem; 2016 Mar; 110():32-42. PubMed ID: 26807543
[TBL] [Abstract][Full Text] [Related]
17. Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell Line CaSki.
Li X; Ran L; Fang W; Wang D
Biomed Pharmacother; 2014 Apr; 68(3):291-7. PubMed ID: 24239273
[TBL] [Abstract][Full Text] [Related]
18. Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
Zeghari-Squalli N; Raymond E; Cvitkovic E; Goldwasser F
Clin Cancer Res; 1999 May; 5(5):1189-96. PubMed ID: 10353756
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells.
Shiragami R; Murata S; Kosugi C; Tezuka T; Yamazaki M; Hirano A; Yoshimura Y; Suzuki M; Shuto K; Koda K
Int J Oncol; 2013 Aug; 43(2):431-8. PubMed ID: 23754252
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
